CollPlant Biotechnologies Ltd Retained Earnings
CollPlant Biotechnologies Ltd (CLGN) had Retained Earnings of -$124.84 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-03-26
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$124.84M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$118.15M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$113.35M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$105.15M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-12-31 | -$124.84M 20-F · filed 2026-03-26 |
| 2025-06-30 | -$118.15M 6-K · filed 2025-08-20 |
| 2024-12-31 | -$113.35M 20-F · filed 2026-03-26 |
| 2024-06-30 | -$105.15M 6-K · filed 2024-08-20 |
| 2023-12-31 | -$96.74M 20-F · filed 2025-03-26 |
| 2023-06-30 | -$87.67M 6-K · filed 2023-08-24 |
| 2022-12-31 | -$89.72M 20-F · filed 2024-04-04 |
| 2022-06-30 | -$80.94M 6-K · filed 2022-08-25 |
| 2021-12-31 | -$72.80M 20-F · filed 2023-03-29 |
| 2021-06-30 | -$65.95M 6-K · filed 2021-08-19 |
| 2020-12-31 | -$73.03M 20-F · filed 2022-03-24 |
| 2020-06-30 | -$70.83M 6-K · filed 2020-08-28 |
| 2019-12-31 | -$67.26M 20-F · filed 2021-03-26 |